In human breast cancer cell line MDA-MB-231, IGF-1 can regulate the secretion of VEGF-C by stimulating the MAPK/ERR1/2 signaling pathway, and the application of ERK1/2 inhibitors can block the effect of IGF-1 on VEGF-C secretion [24]. This evidence concerns the gene IGF1 and breast cancer.